Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen to Sell Chromatography Business to Pall in $32M Deal

NEW YORK , Oct. 28 (GenomeWeb News) - Ciphergen Biosystems will sell its BioSepra process chromatography business to Pall Corporation for $32 million, and the companies will enter into a collaboration the firms said today.


New York-based Pall will establish process proteomics service centers to offer protein purification using Ciphergen's BioSepra's chromatography products and ProteinChip technology.


Ciphergen will retain certain limited rights to access BioSepra's chromatography sorbent technology for use in research and diagnostic markets, the company said.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more